Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q3 2022 Earnings Presentation
6 slides from Aurora Cannabis's earnings presentation, May 12, 2022
Slide 1: Fiscal Q3 2022 Supplemental Information
FISCAL Q3 2022 SUPPLEMENTAL INFORMATION MAY 2022
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Key Takeaways
Key Takeaways Transformation Expect to achieve a positive Adjusted EBITDA run rate by Fiscal H1 FY23 Plan on Track Targeting a total of $150 to $170 million of annualized savings by Fiscal H1 FY23 Medical #1 Canadian LP in global medical cannabis revenues Leadership Growing international med
Slide 4: Q3 2022 Key Financial Highlights
Q3 2022 Key Financial Highlights • Strong Canadian Medical Performance • #1 market share with strong and consistent margins • Direct-to-patient model bypasses provincial distributor • Technology investment drives high and repeatable margin and creates barrier to new entrants Canadian Int’l Medical A
Slide 5: Key Financial Trends
Key Financial Trends Metric FY22 Q3 FY21 Q3 YoY Improvement (%) Adjusted Gross Profit Before Fair Value $27.3m $24.4m 12% Adjustments SG&A and R&D excluding $39.5m $43.0m 8% restructuring costs Adjusted EBITDA ($12.3m) ($20.9m) 41% CAPEX $6.3m $12.2m 48% Adjusted Gross Margin Before Fair Value 54% 4
Slide 6: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: investor.auroramj.com